/
IDXAF
$0.89+$0.69 (+345.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.89 – $0.89
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-190.11
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $250.3K | $3.7M | $9.4M | $2.8M | $4.1M | $4.2M | $794.3K | $254.0K |
| Cost of revenue | $172.4K | $62.0K | $2.4M | $1.3M | $3.2M | $3.9M | $12.3M | $612.0K |
| Gross profit | $77.9K | $96.3K | $7.0M | $1.6M | $848.0K | $231.7K | −$11.5M | −$358.0K |
| Gross margin | 31.1% | 2.6% | 74.9% | 55.8% | 20.7% | 5.6% | -1445.5% | -140.9% |
| R&D | $5.3M | $38.2M | $16.2M | $2.7M | $4.0M | $3.6M | $2.7M | $1.4M |
| Operating income | −$247.1M | −$281.3M | −$226.1M | −$31.4M | −$31.4M | −$26.9M | −$21.1M | −$10.5M |
| EBITDA | −$251.3M | −$273.1M | −$218.6M | −$29.5M | −$29.9M | −$273.9M | −$9.1M | −$8.6M |
| Net income | −$30.2M | −$32.4M | −$229.1M | −$32.5M | −$32.7M | −$26.7M | −$13.6M | −$10.0M |
| Net margin | -12076.0% | -871.0% | -2442.9% | -1146.1% | -798.1% | -643.4% | -1718.1% | -3937.8% |
| EPS (diluted) | -116.00 | -120.00 | -713.47 | -76.96 | -76.37 | -55.86 | -1.93 | -0.22 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.01
Price
$0.89
Implied downside
-99%
Peer comparison
IDEX BIOMETRICS ASA
IDEX BIOMETRICS ASA
Held by traders on TradeandTell
No one on the platform currently holds IDXAF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in IDXAF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-07-07 | 1-for-100reverse |
| 2024-01-09 | 1-for-5reverse |
Recent trades on TradeandTell
No one on the platform has traded IDXAF yet.
